Zebrafish model

Zebrafish: Transforming Early Drug Discovery with Speed, Precision, and Cost-Effectiveness.

Preclinical drug development comes with major challenges that heavily affect the biotech and pharma industries:

High Costs: Drug development costs range from $15M to $100M.
Long Timelines: Preclinical development spans 3 to 7 years.
High Failure Rates: Only ~10% of drug candidates transition successfully to clinical trials.

This reflects the need for more predictive and efficient early-stage testing methods.

Zebrafish is increasingly adopted in drug discovery and biomedical research:

Publication Growth: Over 55,000 PubMed studies feature zebrafish, with 57% published in the past decade.¹

Market Expansion: The zebrafish market is set to grow from $434M to $618M by 2031 (14.5% CAGR).²

Zebrafish Drug Discovery Benefits in Early-Stage Screening

Instead of moving directly from in vitro assays to mammalian models, integrating zebrafish as a complementary in vivo screening tool transforms early-stage drug discovery.

An Integrative Approach To Refine Early-Stage Drug Screening

This approach delivers actionable insights while offering biotech and pharma companies tangible advantages , including improved efficiency, reduced costs, and enhanced predictive success.

Reduce Preclinical Costs with the Zebraifsh model

Reduce Preclinical Costs
Up to 60% cost savings

Faster Time-to-Market of new drugs with the Zebraifsh Model

Faster Time-to-Market
Up to 40% time reduction

Enhance Predictive Success in Drug Discovery With The Zebrafish Model

Enhance Predictive Success
Early-stage zebrafish screening provides high-content functional insights

Reduce Mammalian Animal Use with the Zebrafish Model

Reduce Mammalian Animal Use
Narrowing down #compounds transitioning to mammalian testing

The overall time and cost reduction comes from savings at each step of the process: genetic model generation, zebrafish maintenance in the animal facility, and—most significantly—the drug screening phase:

time and cost reduction in drug discovery with zebrafish model

💡 How Zebrafish Helped Slash Preclinical Costs by 60% – A Real Success Story

Talk to an Expert and start saving!

84% human gene homology, 60% cost savings,
and 40% faster results – all possible with zebrafish.

REQUEST MORE INFORMATION

Regulatory Validation of the Zebrafish Model: EMA and FDA Endorsements

Both the EMA and the FDA recognize the value of alternative models, including zebrafish, in preclinical research:

EMA Perspective: The EMA's non-clinical guidelines encourage the use of alternative models that align with the 3Rs principles (Replacement, Reduction, Refinement) to enhance the ethical aspects of scientific research.³
FDA Guidance: The FDA outlines the importance of selecting relevant animal species for preclinical studies, emphasizing that alternative models can provide critical insights into drug safety and efficacy.⁴

They recognize zebrafish as a complementary model, pivotal to an integrative approach. Zebrafish enhance, rather than replace, mammalian models, acting as a seamless bridge to more comprehensive preclinical evaluations.

Key Fact: Implementing zebrafish models in early-stage drug discovery aligns with regulatory expectations and supports the ethical imperative to reduce reliance on traditional mammalian models.

How the Zebrafish Model Delivers Unmatched Benefits in Drug Discovery?

The zebrafish model offers unparalleled advantages in early preclinical research, combining the best of in vitro simplicity and mammalian complexity. Here's why zebrafish stand out:

Whole-Organism Insights
Zebrafish enable real-time observation of drug effects across organ systems, providing systemic insights that cell cultures cannot replicate.
Cost-Effectiveness
Maintaining zebrafish is significantly cheaper than housing mammalian models like mice, making them a budget-friendly option for early drug discovery.
Rapid Development
Zebrafish embryos develop major organs within 72 hours, accelerating research timelines compared to the longer gestation periods of mice.
High Scalability
Zebrafish are ideal for high-throughput screening, producing hundreds of embryos per week and enabling large-scale testing.
Clinical Relevance
Zebrafish share 84% of human disease-related genes, offering reliable insights into drug mechanisms and potential human outcomes.
Transparent Embryos
Zebrafish embryos are optically clear, allowing researchers to monitor development and physiological responses without invasive techniques.

💡 Zebrafish Model Organism: All You Need To Know

Why Use Zebrafish Instead of Mice or Cells?

Comparative Analysis of Zebrafish, Mice, and Cell Culture Models for Research — **Connectome**: is a comprehensive map of neural connections in the brain, which is essential for understanding its structure and function.
*Embryos hatch by 2-3 days post-fertilization (dpf) and are free-feeding larvae shortly after. By 5 dpf the nervous, circulatory, and digestive systems are fully operational, and larvae exhibit complex behaviors like swimming and sensory responses.

reproductive output of mice compared to the zebrafish model

💡 A Detailed Comparison of Common Model Organism

Fields of development

Developmental biology

Oncology

Toxicology

Teratology

Genetics

Neurobiology

Stem cell research

Regenerative medicine

Evolutionary theory

Reproductive studies

Environmental sciences

Ophthalmology

The zebrafish model has been particularly well-received in therapeutic areas like neurodegenerative diseases, cardiovascular research, and oncology, where traditional mammalian models face challenges in mimicking human conditions.

Zebrafish in Action: Success Stories

The following examples showcase the zebrafish model's versatility in advancing the understanding and treatment of complex diseases.

Zebrafish Advancing Disease Understanding and Modeling

Parkinson Disease

Zebrafish models have been instrumental in studying the mechanisms of dopaminergic neuron degeneration underlying Parkinson's disease. Zebrafish MPTP models are valuable for studying disease progression and testing therapeutic interventions.

Alzheimer Disease

Utilizing zebrafish, researchers have gained insights into amyloid-beta toxicity and tau pathology, contributing to Alzheimer's disease research and drug discovery efforts.

Myocardial infarction

Zebrafish models have identified compounds that stimulate cardiac tissue regeneration, a breakthrough in treating myocardial infarction.

Dilated cardiomyopathy

Through zebrafish models, scientists have explored the genetic mutations and pathophysiological processes leading to dilated cardiomyopathy, aiding in the search for effective treatments.

Congenital Heart Disease

The transparency and genetic tractability of zebrafish embryos have allowed for the investigation of congenital heart defects, enhancing our understanding of their development and potential interventions.

Melanoma

Zebrafish have proven to be a powerful model for studying tumor progression in real time and metastasis. In particular, zebrafish models have been used to study melanoma, where genetic modifications mimicking human cancer mutations were made (in mitfa and BRAF V600E genes), allowing for the rapid screening of anti-cancer drugs.

🔗Explore a curated collection of studies where zebrafish have significantly advanced disease understanding and modeling

Zebrafish Efficacy Testing in Action: Discoveries Advancing to Clinical Trials

Zebrafish have played a pivotal role in identifying compounds that have progressed to clinical trials or been approved as therapies.

Clemizole: An antihistamine identified through zebrafish models for its significant antiseizure effects in Dravet syndrome, is currently undergoing a Phase II clinical trial as an adjunctive therapy for children and adults with this condition.⁵^,⁶
Vandetanib: A tyrosine kinase inhibitor used in the treatment of medullary thyroid carcinoma, has demonstrated anti-angiogenic effects in zebrafish models, aiding in understanding its efficacy and safety profiles.⁷
Belzutifan: An HIF-2α inhibitor recently FDA-approved for treating von Hippel-Lindau disease-associated tumors, has been studied using zebrafish to evaluate its impact on tumor angiogenesis and progression.⁸

These examples highlight how zebrafish models accelerate drug discovery, reduce risks, and optimize therapeutic outcomes.

🔗Explore the more than 10 marketed compounds tested in zebrafish

Contact us today to see how
zebrafish can optimize
your pipeline